EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer

Xinyang Li, Hugues Escoffier iD, Thomas Sauter iD, Mahvash Tavassoli iD

Cancers · 15.01.2025 · 17 (2) · 267

DOI: 10.3390/cancers17020267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 15.01.2025. Verfasst von Xinyang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Head and Neck Oncology Group, Centre for Host Microbiome Interaction, King's College London, Hodgkin Building, London SE1 1UL, UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King's College London, Joint PhD program between King’s College London and China Scholarship Council, Luxembourg National Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer-associated fibroblasts have been reported to play a central role in driving cancer progression, promoting metastasis, and conferring resistance to therapy in HNSCC.

Methods

Indirect and direct co-culture models of HPV-positive and HPV-negative HNSCC cells with fibroblasts were developed to study the effect of fibroblasts on cancer cells. ELISA was used to measure IL-6 secretion in these models. To dissect the underlying signalling mechanisms, the effects of IL-6, an IL-6 receptor (IL-6R) inhibitor, a MAPK/ERK inhibitor, and a JAK/STAT inhibitor were evaluated. Epithelial-to-mesenchymal transition (EMT) was assessed by measuring EMT markers and conducting scratch assays and spheroid assays. Radioresistance was evaluated using clonogenic assays. Additionally, radioresistant (RR) cell lines were established from parental cells to examine the correlation between radioresistance and EMT.

Results

Fibroblasts were found to drive EMT-like changes and heightened radioresistance in HNSCC cells through IL-6 secretion. Remarkably, these Fb-driven effects were robustly reversed using IL-6R and MAPK/ERK inhibitors in both HPV-positive and HPV-negative cell lines, whereas JAK/STAT inhibitors proved effective only in HPV-negative cells. RR cell lines exhibit a more aggressive phenotype than their parental counterparts, marked by pronounced EMT features and heightened resistance to radiotherapy. Importantly, these aggressive characteristics were substantially attenuated by targeting IL-6R or MAPK/ERK pathways.

Conclusions

This study highlights the critical role of fibroblast-secreted IL-6 in driving and maintaining EMT and radioresistance in HNSCC, resulting in a more aggressive tumour phenotype. Targeting the IL-6/IL-6R/ERK pathway emerges as a promising therapeutic approach for combating CAF-driven tumour progression and improving clinical outcomes in patients with aggressive, therapy-resistant HNSCC.

Schlagwörter

Stichwörter der Autor:innen

IL-6cancer associated fibroblastsepithelial-to-mesenchymal transitionhead and neck squamous cell carcinomaradioresistance

Autor:innen und Institutionen

  • Head and Neck Oncology Group, Centre for Host Microbiome Interaction, King's College London, Hodgkin Building, London SE1 1UL, UK.
  • Department of Life Sciences and Medicine, University of Luxembourg, L-4370 Belvaux, Luxembourg.

ORCID-Profile: Hugues Escoffier, Thomas Sauter, Mahvash Tavassoli

Förderung

  • King's College London
  • Joint PhD program between King’s College London and China Scholarship Council
  • Luxembourg National Research Fund

Zitieren

APA

Li, X., Escoffier, H., Sauter, T., & Tavassoli, M. (2025). Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer. Cancers, 17(2), 267. https://doi.org/10.3390/cancers17020267

Vancouver

Li X, Escoffier H, Sauter T, Tavassoli M. Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer. Cancers. 2025;17(2):267. doi:10.3390/cancers17020267

BibTeX
@article{Li2025,
  author = {Li, Xinyang and Escoffier, Hugues and Sauter, Thomas and Tavassoli, Mahvash},
  title = {Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck Cancer},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {267},
  doi = {10.3390/cancers17020267}
}
Kostenlos starten →